Cost Effectiveness of Novel Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation Depending on the Quality of Warfarin Anticoagulation Control

被引:0
作者
Andrej Janzic
Mitja Kos
机构
[1] University of Ljubljana,Faculty of Pharmacy
来源
PharmacoEconomics | 2015年 / 33卷
关键词
Warfarin; Dabigatran; Rivaroxaban; Apixaban; CHADS2 Score;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:395 / 408
页数:13
相关论文
共 240 条
[1]  
Camm AJ(2010)Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J. 31 2369-2429
[2]  
Kirchhof P(1991)Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke. 22 983-988
[3]  
Lip GY(2003)Atrial fibrillation is associated with severe acute ischemic stroke Neuroepidemiology. 22 118-123
[4]  
Schotten U(2008)Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies BMJ. 336 376-379
[5]  
Savelieva I(2007)Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation Ann Intern Med. 146 857-867
[6]  
Ernst S(2002)Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis JAMA. 288 2441-2448
[7]  
Wolf PA(2005)Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population Heart. 91 472-477
[8]  
Abbott RD(2008)Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range Circulation. 118 2029-2037
[9]  
Kannel WB(2007)Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V Arch Intern Med. 167 239-245
[10]  
Dulli DA(2006)Patterns of use of antithrombotic therapy and quality of anticoagulation among patients with non-valvular atrial fibrillation in clinical practice Int J Clin Pract. 60 258-264